On the recordMarch 28, 2012
The second part will remove red tape that keeps the FDA from consulting with the experts in health care and biotechnology.
Source
congress.govThe second part will remove red tape that keeps the FDA from consulting with the experts in health care and biotechnology.
Franken emphasizes the importance of reducing bureaucratic barriers for FDA consultations.
Share
More from Al Franken
He’s going to send it out. He’s, as he said, you know, before the commercial, he said he’s destroyed the Senate. He did that by -- he did more filibusters of executive nominees during Obama than been done in the previous history of the…
One thing that people of West Virginia really want is lower-priced insulin. And that is in this bill, finally.
Never thought I’d say a prayer for Charlie Kirk. But here goes. Political violence has no place in this country.